Today: 27 June 2026

Ramp Company Valuation Today (Dec. 14, 2025): The $32 Billion Benchmark, Fresh Private-Market Signals, and What Investors Are Watching Next

Ramp Company Valuation Today (Dec. 14, 2025): The $32 Billion Benchmark, Fresh Private-Market Signals, and What Investors Are Watching Next

Ramp’s latest disclosed valuation remains $32 billion, set in a $300 million primary funding round and employee tender offer announced November 17, 2025. Private-market platforms Forge and Notice, updated December 14, show Ramp shares trading near $92, with implied valuations close to the recent round. Ramp is not publicly traded. Data providers note these are derived estimates, not public market prices.
14 December 2025
Ripple Valuation Today (Dec. 14, 2025): Why Ripple Labs Is Being Priced Around $40 Billion—and What Could Move It Next

Ripple Valuation Today (Dec. 14, 2025): Why Ripple Labs Is Being Priced Around $40 Billion—and What Could Move It Next

Ripple Labs’ valuation remains anchored at about $40 billion, based on a $500 million investment round in November and a $1 billion tender offer earlier this year, both reported by Reuters. The U.S. has conditionally approved Ripple to set up a national trust bank. A $300 million South Korea-focused vehicle is seeking Ripple shares, signaling increased institutional interest.
14 December 2025
··
Scale AI Valuation in 2025: Latest Read on the $29B Meta Deal, Private-Market Pricing Signals, and What Comes Next (Updated Dec. 14, 2025)

Scale AI Valuation in 2025: Latest Read on the $29B Meta Deal, Private-Market Pricing Signals, and What Comes Next (Updated Dec. 14, 2025)

Scale AI’s most recent headline valuation remains $29 billion, set by Meta’s minority investment and expanded partnership in June 2025. New secondary-market pricing, however, shows shares trading at levels implying valuations between $11.6 billion and $18.9 billion. Private-market transactions remain limited and sporadic. No official daily valuation exists for the company.
14 December 2025
·
Sandisk (SNDK) Stock News Today: Downgrade Sparks Sharp Selloff, Analyst Price Targets, and 2026 Outlook (Dec. 14, 2025)

Sandisk (SNDK) Stock News Today: Downgrade Sparks Sharp Selloff, Analyst Price Targets, and 2026 Outlook (Dec. 14, 2025)

Sandisk shares closed Friday at $206.18, down 14.66% after GF Securities downgraded the stock to “Hold” and cut its price target to $239. The drop marked the S&P 500’s steepest percentage decline of the day. Trading volume topped 12 million shares. The move followed a broader tech selloff, with the Philadelphia semiconductor index down 5.1%.
14 December 2025
Oklo Inc. Stock (NYSE: OKLO) News, Forecasts and Analyst Outlook on Dec. 14, 2025 — ATM Offering, Sector Selloff, and What Investors Are Watching

Oklo Inc. Stock (NYSE: OKLO) News, Forecasts and Analyst Outlook on Dec. 14, 2025 — ATM Offering, Sector Selloff, and What Investors Are Watching

Oklo Inc. shares closed at $87.42 on Dec. 12, down 15.13% after a weeklong slide tied to weakness in uranium and nuclear-related stocks and reports of delayed data center projects. The company’s $1.5 billion at-the-market equity program, disclosed Dec. 4, remains a key concern for investors, raising dilution risk as Oklo seeks capital to fund reactor development.
14 December 2025
·
Modine Manufacturing Company (MOD) Stock Today: What’s Driving the Sell-Off, Fresh Analyst Targets, and 2026 Outlook (Dec. 14, 2025)

Modine Manufacturing Company (MOD) Stock Today: What’s Driving the Sell-Off, Fresh Analyst Targets, and 2026 Outlook (Dec. 14, 2025)

Modine Manufacturing shares closed at $139.88 on Friday, down 15.32% after a volatile session that ended a strong 2025 rally. G2 Investment Partners increased its stake by 52.9% in Q2, while D.A. Davidson reiterated a Buy rating with a $200 target. The drop follows renewed concerns over margin pressure despite continued data center demand.
14 December 2025
·
Anthropic Valuation 2025: Claude Maker’s $183B Price Tag Meets $300B+ Funding Talk as IPO Buzz Builds (Updated Dec. 14, 2025)

Anthropic Valuation 2025: Claude Maker’s $183B Price Tag Meets $300B+ Funding Talk as IPO Buzz Builds (Updated Dec. 14, 2025)

Anthropic closed a $13 billion Series F round in September 2025, setting its post-money valuation at $183 billion. Reuters reports the company is in talks for a new funding round that could push its valuation above $300 billion, though this figure is not confirmed. Anthropic’s revenue run-rate reportedly grew from $1 billion to over $5 billion in 2025, with internal targets as high as $26 billion for 2026.
14 December 2025
Celestica Inc. Stock (CLS) Update: Why Shares Slumped, What Analysts Forecast, and the 2026 Outlook (Dec. 14, 2025)

Celestica Inc. Stock (CLS) Update: Why Shares Slumped, What Analysts Forecast, and the 2026 Outlook (Dec. 14, 2025)

Celestica shares fell nearly 13% Friday, closing at $306.50 on the NYSE and C$421.77 on the TSX, after a broad tech selloff and renewed “AI bubble” concerns. New institutional filings Sunday showed both buying and trimming of positions. Management reaffirmed a $16 billion revenue target and $8.20 adjusted EPS for 2026. RBC and Goldman maintained bullish price targets at $400 and $440, respectively.
14 December 2025
··
Databricks Valuation Today (14/12/2025): $134B Fundraising Talk, $100B Baseline, and What Investors Watch Next

Databricks Valuation Today (14/12/2025): $134B Fundraising Talk, $100B Baseline, and What Investors Watch Next

Databricks announced in August 2025 a Series K funding round valuing the company at over $100 billion. Reuters reported on Nov. 30 that Databricks is in talks to raise $5 billion at a $134 billion valuation, though the company declined to comment. The firm recently surpassed a $4 billion revenue run-rate and reported positive free cash flow. Secondary markets list its valuation at $100 billion as of Dec. 14.
14 December 2025
xAI Valuation Today (Dec. 14, 2025): Why Elon Musk’s AI Startup Is Being Priced at $200B–$230B and What Comes Next

xAI Valuation Today (Dec. 14, 2025): Why Elon Musk’s AI Startup Is Being Priced at $200B–$230B and What Comes Next

Elon Musk’s xAI is in advanced talks to raise $15 billion at a reported $230 billion valuation, according to multiple outlets as of December 14, 2025. The distinction between pre- and post-money valuation remains unclear. Musk has publicly disputed some fundraising reports, adding uncertainty. The round is expected to close around December 19.
14 December 2025
··
SpaceX Valuation Surges to $800 Billion in Insider Share Sale—What the Latest IPO Forecasts Say for 2026 (Updated Dec. 14, 2025)

SpaceX Valuation Surges to $800 Billion in Insider Share Sale—What the Latest IPO Forecasts Say for 2026 (Updated Dec. 14, 2025)

SpaceX set its valuation at about $800 billion after approving a secondary share sale at $421 per share, according to a Dec. 12 letter from CFO Bret Johnsen reviewed by Reuters. The deal allows up to $2.56 billion in shares to be sold to investors and SpaceX itself. The company is preparing for a possible IPO in 2026 but has not set a final timeline or valuation.
14 December 2025
·
OpenAI Valuation Today (Dec. 14, 2025): The $500 Billion Benchmark, $600B Secondary Signals, and the New Money Questions Investors Are Asking

OpenAI Valuation Today (Dec. 14, 2025): The $500 Billion Benchmark, $600B Secondary Signals, and the New Money Questions Investors Are Asking

OpenAI’s latest employee share sale set its valuation at $500 billion this fall. As of December 14, 2025, secondary market data pegs it near $500 billion, while some private trades and proxy estimates suggest figures as high as $600 billion and $750 billion. The company faces scrutiny over whether its business model can sustain mounting infrastructure costs.
14 December 2025
·
Fermi Inc. (FRMI) Stock News Today: $150M Funding Deal Terminated, Project Matador Updates, and Analyst Price Targets (Dec. 14, 2025)

Fermi Inc. (FRMI) Stock News Today: $150M Funding Deal Terminated, Project Matador Updates, and Analyst Price Targets (Dec. 14, 2025)

Fermi Inc. shares plunged 34% Friday after its first prospective tenant terminated a $150 million construction funding agreement for Project Matador in West Texas. The company disclosed no funds had been drawn and lease talks continue, but the stock saw record volatility and heavy volume. FRMI closed around $10.09, down sharply from post-IPO highs. Fermi remains pre-revenue and is seeking new tenants for 2026.
14 December 2025
RH Stock News & Forecast (NYSE:RH) on Dec. 14, 2025: Q3 FY2025 Earnings, Guidance Reset, and New Analyst Price Targets

RH Stock News & Forecast (NYSE:RH) on Dec. 14, 2025: Q3 FY2025 Earnings, Guidance Reset, and New Analyst Price Targets

RH shares rose 5.7% Friday to $162.01 after reporting Q3 revenue of $884 million and net income of $36 million, both up 9% year over year. The company’s updated outlook cited ongoing margin pressure from tariffs and international expansion, leading several analysts to cut price targets. RH guided Q4 revenue growth of 7%–8% and an adjusted operating margin of 12.5%–13.5%. Wall Street consensus remains neutral.
14 December 2025
··
CCC Intelligent Solutions Holdings Inc. Stock (NASDAQ: CCC): $500M Buyback, Debt-Funded ASR, Analyst Price Targets, and What’s Next (Dec. 14, 2025)

CCC Intelligent Solutions Holdings Inc. Stock (NASDAQ: CCC): $500M Buyback, Debt-Funded ASR, Analyst Price Targets, and What’s Next (Dec. 14, 2025)

CCC Intelligent Solutions authorized a $500 million share repurchase program on Dec. 12, including a $300 million accelerated share repurchase funded by new term-loan borrowings. The company’s Nasdaq ticker changed to “CCC” on Oct. 31. Shares closed at $7.68 on Dec. 14, with a market cap of about $4.93 billion. The ASR with Bank of America is expected to settle by Q2 2026.
14 December 2025
·
Immunovant (IMVT) Stock News and Forecast for Dec. 14, 2025: $550M Financing Closes, Roivant Buys $350M, Analysts Update Targets

Immunovant (IMVT) Stock News and Forecast for Dec. 14, 2025: $550M Financing Closes, Roivant Buys $350M, Analysts Update Targets

Immunovant closed a $550 million stock offering on December 12, 2025, selling 26.2 million shares at $21 each. Roivant Sciences bought 16.7 million shares, investing about $350 million and increasing its stake. IMVT shares ended the week at $26.42, up 6.6% after heavy trading. The company plans to use proceeds to fund clinical trials and general operations.
14 December 2025
·
Amicus Therapeutics (FOLD) Stock News, Forecasts and Analyst Outlook on Dec. 14, 2025: What’s Driving the Rally?

Amicus Therapeutics (FOLD) Stock News, Forecasts and Analyst Outlook on Dec. 14, 2025: What’s Driving the Rally?

Amicus Therapeutics shares closed at $10.55 Friday, up 6.6% after hitting a 52-week high of $10.85. Renewed bullish analyst coverage, including a Zacks “strong buy” and a mean price target of $15.90, followed the move. The company’s profitability trajectory and recent earnings have drawn increased attention from investors.
14 December 2025
··
lululemon athletica (LULU) Stock News Today (Dec. 14, 2025): CEO Transition, Q3 Beat, Buyback Boost, and Nasdaq-100 Exit in Focus

lululemon athletica (LULU) Stock News Today (Dec. 14, 2025): CEO Transition, Q3 Beat, Buyback Boost, and Nasdaq-100 Exit in Focus

Lululemon shares jumped 9.6% to $204.97 on Dec. 12 after the company announced CEO Calvin McDonald will step down at the end of January 2026. The leadership change came alongside a Q3 earnings beat, raised 2025 guidance, and a $1 billion buyback increase. LULU is set to exit the Nasdaq-100 index. The stock is down nearly 48% year-to-date.
14 December 2025
··
1 … 1,416 1,417 1,418 1,419 1,420 … 2,114

Stock Market Today

  • Hamilton U.S. T-Bill YIELD MAXIMIZER ETF (HBIL:CA) Market Analysis June 27, 2026
    June 27, 2026, 2:59 PM EDT. On June 27, 2026, the Hamilton U.S. T-Bill YIELD MAXIMIZER ETF (HBIL:CA) received neutral ratings for near, mid, and long-term outlooks according to AI-generated signals. No long trading positions are advised at this time. The only recommendation is a short position near 14.65 Canadian dollars with a stop loss set at 14.72. The ETF tracks U.S. Treasury bills, often viewed as low-risk government debt. Investors should consider the neutral market stance and the absence of a mid or long-term bullish signal before making trading decisions.

Latest articles

AT&T (NYSE:T) bounces, traders watch AWS-3 bill and yield

AT&T (NYSE:T) bounces, traders watch AWS-3 bill and yield

27 June 2026
AT&T shares jumped 1.34% to $22.72 on Friday with double average volume after winning just 10 AWS-3 spectrum licenses for $120.8 million—only 3.8% of Verizon’s $3.16 billion spend—supporting near-term cash flow and dividend prospects ahead of the July 10 record date and July 22 earnings call.
Coca-Cola (NYSE:KO) stock run brings IRS $20 billion case into view for investors

Coca-Cola (NYSE:KO) stock run brings IRS $20 billion case into view for investors

27 June 2026
Coca-Cola (KO) surged 2.75% to $82.63 Friday, outpacing staples as a federal appeals court appeared receptive to KO’s arguments in its $14 billion IRS tax dispute; the stock’s $3.24 gain since June 18 was driven mostly by Friday’s $2.21 jump, with analysts noting the case’s outcome could impact billions in potential refunds or liabilities.
Fiserv (NASDAQ:FISV) sees stock lift after CEO surprise

Fiserv (NASDAQ:FISV) sees stock lift after CEO surprise

27 June 2026
Fiserv jumped 4.8% for the week, defying market declines after insider buys clustered around $49–$51 and a CEO change; heavy Friday trading set the $49–$50 level as a key test for investor confidence in the shortened trading week, with the stock closing at $49.45—just below the insiders’ average purchase price.
Go toTop